Immunomodulator agent-related lymphoproliferative disorders
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 22 (12) , 1532-1540
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A transient benign lymph node-based proliferation of T-cells simulating non-Hodgkin lymphoma in a patient with psoriasis treated with tumor necrosis factor alpha and CD11a antagonistsDiagnostic Pathology, 2008
- A Review of Malignancies Observed during Efalizumab (Raptiva®) Clinical Trials for Plaque PsoriasisDermatology, 2006
- Use of biologics in rheumatoid arthritis: Where are we going?American Journal of Health-System Pharmacy, 2006
- Risk of haematopoietic cancer in patients with inflammatory bowel diseaseGut, 2005
- Aggressive cutaneous T-cell lymphomas after TNFα blockadeJournal of the American Academy of Dermatology, 2004
- Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Leukemia, 2003
- Lymphoma subtypes in patients with rheumatoid arthritis: Increased proportion of diffuse large B cell lymphomaArthritis & Rheumatism, 2003
- Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug AdministrationArthritis & Rheumatism, 2002
- T-Cell Clonality Determination Using Polymerase ChainReaction (PCR) Amplification of the T-Cell Receptorgamma-Chain Gene and Capillary Electrophoresis ofFluorescently Labeled PCR ProductsAmerican Journal of Clinical Pathology, 2000
- Hodgkin's Disease and Lymphoproliferations Resembling Hodgkin's Disease in Patients Receiving Long-Term Low-Dose Methotrexate TherapyAmerican Journal of Surgical Pathology, 1996